文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

动脉粥样硬化的病理生理学。

Pathophysiology of Atherosclerosis.

机构信息

Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48940 Leioa, Bizkaia, Spain.

Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa, Bizkaia, Spain.

出版信息

Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346.


DOI:10.3390/ijms23063346
PMID:35328769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954705/
Abstract

Atherosclerosis is the main risk factor for cardiovascular disease (CVD), which is the leading cause of mortality worldwide. Atherosclerosis is initiated by endothelium activation and, followed by a cascade of events (accumulation of lipids, fibrous elements, and calcification), triggers the vessel narrowing and activation of inflammatory pathways. The resultant atheroma plaque, along with these processes, results in cardiovascular complications. This review focuses on the different stages of atherosclerosis development, ranging from endothelial dysfunction to plaque rupture. In addition, the post-transcriptional regulation and modulation of atheroma plaque by microRNAs and lncRNAs, the role of microbiota, and the importance of sex as a crucial risk factor in atherosclerosis are covered here in order to provide a global view of the disease.

摘要

动脉粥样硬化是心血管疾病(CVD)的主要危险因素,是全球范围内导致死亡的主要原因。动脉粥样硬化由内皮细胞激活引发,随后一系列事件(脂质、纤维成分和钙化的积累)引发血管狭窄和炎症途径的激活。由此产生的动脉粥样硬化斑块,以及这些过程,导致心血管并发症。本综述重点介绍了动脉粥样硬化发展的不同阶段,从内皮功能障碍到斑块破裂。此外,还介绍了 microRNAs 和 lncRNAs 对动脉粥样硬化斑块的转录后调控和调节、微生物组的作用以及性别作为动脉粥样硬化的关键风险因素的重要性,以便全面了解该疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/d9839d921ea0/ijms-23-03346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/f01602cae46e/ijms-23-03346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/9e659bb8536b/ijms-23-03346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/d9839d921ea0/ijms-23-03346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/f01602cae46e/ijms-23-03346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/9e659bb8536b/ijms-23-03346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg

相似文献

[1]
Pathophysiology of Atherosclerosis.

Int J Mol Sci. 2022-3-20

[2]
The role of metabolic disorders in the development of atherosclerosis.

Cell Mol Biol (Noisy-le-grand). 2024-10-8

[3]
Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.

Front Immunol. 2018-4-17

[4]
Microcalcifications, Their Genesis, Growth, and Biomechanical Stability in Fibrous Cap Rupture.

Adv Exp Med Biol. 2018

[5]
Thrombosis formation on atherosclerotic lesions and plaque rupture.

J Intern Med. 2014-9-25

[6]
Inflammation in atherosclerosis: a cause or a result of vascular disorders?

J Cell Mol Med. 2012-9

[7]
Extracellular Vesicles in Atherosclerosis: State of the Art.

Int J Mol Sci. 2023-12-27

[8]
From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.

Pharmacol Ther. 2007-1

[9]
[Pathology of AtheroThrombosIS (ATIS)].

Drugs. 2010-11-1

[10]
Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.

Ann Med. 2017-8-22

引用本文的文献

[1]
Ex Vivo Characterization of Peritoneal Macrophages from Novel ABCA1-LSL and ABCG1-LSL Mice for Macrophage-Specific ABC-Transporter Overexpression.

Biology (Basel). 2025-8-18

[2]
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease.

World J Hepatol. 2025-8-27

[3]
Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.

Cell Commun Signal. 2025-9-2

[4]
The Association Between Neutrophil-to-Lymphocyte Ratio, Atherogenic Index of Plasma, and Cardiovascular Disease Incidence.

Mediators Inflamm. 2025-8-22

[5]
Nutritional-inflammatory balance assessed by advanced lung cancer inflammation index and its association with all-cause mortality in coronary heart disease : a retrospective cohort study.

J Health Popul Nutr. 2025-8-31

[6]
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features.

Life (Basel). 2025-8-3

[7]
Salusins in Atherosclerosis: Dual Roles in Vascular Inflammation and Remodeling.

Biomedicines. 2025-8-15

[8]
Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers.

Biomedicines. 2025-7-31

[9]
Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway.

Biomolecules. 2025-7-25

[10]
Cys-Ala-Gly Peptides and Amphiphilic mPEG-PLGA Polymer Modified ZE21B Magnesium Alloy for Enhanced Anticorrosion and Pro-Endothelialization Potential.

ACS Omega. 2025-8-5

本文引用的文献

[1]
Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability.

Front Cardiovasc Med. 2021-8-3

[2]
The iterative lipid impact on inflammation in atherosclerosis.

Curr Opin Lipidol. 2021-10-1

[3]
Efferocytosis of vascular cells in cardiovascular disease.

Pharmacol Ther. 2022-1

[4]
Nitric oxide signalling in kidney regulation and cardiometabolic health.

Nat Rev Nephrol. 2021-9

[5]
Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.

Cell Death Dis. 2021-5-25

[6]
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.

EMBO Mol Med. 2021-5-7

[7]
The changing landscape of atherosclerosis.

Nature. 2021-4

[8]
The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptor.

iScience. 2021-1-21

[9]
Microbiota-Mediated Immune Regulation in Atherosclerosis.

Molecules. 2021-1-1

[10]
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation.

Front Immunol. 2020

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索